Inhibition of Hepatic CYP2D6 by the Active N-Oxide Metabolite of Sorafenib

Michael Murray, Tina B. Gillani, Tristan Rawling, Pramod C. Nair

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Inhibition of Hepatic CYP2D6 by the Active N-Oxide Metabolite of Sorafenib'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science